Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei V Gudkov

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Nature Medicine|December 8, 2004
Cancer drug discovery: the wisdom of imprecisionAndrei V Gudkov
Nature Medicine|November 2, 2002
Converting p53 from a killer into a healerAndrei V Gudkov
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
In regard to Schuller et Al. (Int J Radiat Oncol Biol Phys 2007;68:205-210)Andrei V Gudkov, Anatoly Gleiberman
Nature Reviews. Cancer|February 4, 2003
The role of p53 in determining sensitivity to radiotherapyAndrei V Gudkov, Elena A Komarova
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Genetic suppressor elements in the characterization and identification of tumor suppressor genesIgor B Roninson, Andrei V Gudkov
The Journal of Clinical Investigation|June 26, 2010
Radioprotection: smart games with deathAndrei V Gudkov, Elena A Komarova
Oncotarget|August 16, 2013
ATM is activated in blood monocytes after tumor radiationAndrei V Gudkov, Elena A Komarova
Biochemical and Biophysical Research Communications|May 4, 2005
Prospective therapeutic applications of p53 inhibitorsAndrei V Gudkov, Elena A Komarova
Cold Spring Harbor Perspectives in Medicine|August 24, 2016
p53 and the Carcinogenicity of Chronic InflammationAndrei V Gudkov, Elena A Komarova
Human Molecular Genetics|September 26, 2007
Dangerous habits of a security guard: the two faces of p53 as a drug targetAndrei V Gudkov, Elena A Komarova
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Nature Medicine|December 8, 2004
Cancer drug discovery: the wisdom of imprecisionAndrei V Gudkov
Nature Medicine|November 2, 2002
Converting p53 from a killer into a healerAndrei V Gudkov
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
In regard to Schuller et Al. (Int J Radiat Oncol Biol Phys 2007;68:205-210)Andrei V Gudkov, Anatoly Gleiberman
Nature Reviews. Cancer|February 4, 2003
The role of p53 in determining sensitivity to radiotherapyAndrei V Gudkov, Elena A Komarova
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2003
Genetic suppressor elements in the characterization and identification of tumor suppressor genesIgor B Roninson, Andrei V Gudkov
The Journal of Clinical Investigation|June 26, 2010
Radioprotection: smart games with deathAndrei V Gudkov, Elena A Komarova
Oncotarget|August 16, 2013
ATM is activated in blood monocytes after tumor radiationAndrei V Gudkov, Elena A Komarova
Biochemical and Biophysical Research Communications|May 4, 2005
Prospective therapeutic applications of p53 inhibitorsAndrei V Gudkov, Elena A Komarova
Cold Spring Harbor Perspectives in Medicine|August 24, 2016
p53 and the Carcinogenicity of Chronic InflammationAndrei V Gudkov, Elena A Komarova
Human Molecular Genetics|September 26, 2007
Dangerous habits of a security guard: the two faces of p53 as a drug targetAndrei V Gudkov, Elena A Komarova
Pageof 15